KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Pension (2016 - 2025)

Historic Pension for Abbott Laboratories (ABT) over the last 16 years, with Q3 2025 value amounting to $6.7 billion.

  • Abbott Laboratories' Pension rose 209.06% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 billion, marking a year-over-year increase of 209.06%. This contributed to the annual value of $6.7 billion for FY2024, which is 310.93% down from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' Pension is $6.7 billion, which was up 209.06% from $6.8 billion recorded in Q2 2025.
  • Abbott Laboratories' 5-year Pension high stood at $9.1 billion for Q2 2021, and its period low was $6.6 billion during Q2 2024.
  • Moreover, its 5-year median value for Pension was $7.0 billion (2023), whereas its average is $7.6 billion.
  • Its Pension has fluctuated over the past 5 years, first plummeted by 1669.29% in 2023, then skyrocketed by 370.54% in 2025.
  • Over the past 5 years, Abbott Laboratories' Pension (Quarter) stood at $8.8 billion in 2021, then dropped by 14.24% to $7.5 billion in 2022, then decreased by 7.64% to $6.9 billion in 2023, then fell by 3.11% to $6.7 billion in 2024, then grew by 0.12% to $6.7 billion in 2025.
  • Its Pension was $6.7 billion in Q3 2025, compared to $6.8 billion in Q2 2025 and $6.6 billion in Q1 2025.